 Anna Furniss
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 12 | 2025 | 1472 | 0.740 |
Why?
| | Turner Syndrome | 3 | 2025 | 65 | 0.590 |
Why?
| | Neurodevelopmental Disorders | 4 | 2025 | 210 | 0.540 |
Why?
| | Parents | 7 | 2025 | 1440 | 0.500 |
Why?
| | Papillomavirus Vaccines | 4 | 2024 | 322 | 0.470 |
Why?
| | Mental Disorders | 4 | 2025 | 1130 | 0.450 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2025 | 39 | 0.390 |
Why?
| | Overweight | 5 | 2023 | 588 | 0.380 |
Why?
| | Klinefelter Syndrome | 2 | 2025 | 70 | 0.380 |
Why?
| | Transgender Persons | 2 | 2024 | 200 | 0.320 |
Why?
| | Reminder Systems | 3 | 2016 | 174 | 0.310 |
Why?
| | Text Messaging | 3 | 2016 | 179 | 0.300 |
Why?
| | Safety-net Providers | 2 | 2021 | 124 | 0.290 |
Why?
| | Papillomavirus Infections | 3 | 2024 | 382 | 0.260 |
Why?
| | Weight Loss | 3 | 2017 | 791 | 0.250 |
Why?
| | Health Surveys | 3 | 2025 | 513 | 0.250 |
Why?
| | Anxiety | 2 | 2025 | 1090 | 0.240 |
Why?
| | Rural Health Services | 2 | 2024 | 141 | 0.230 |
Why?
| | Weight Reduction Programs | 2 | 2017 | 117 | 0.230 |
Why?
| | Adolescent | 19 | 2025 | 22130 | 0.220 |
Why?
| | Hypertension | 3 | 2022 | 1254 | 0.220 |
Why?
| | Sex Chromosome Disorders | 1 | 2025 | 28 | 0.220 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2024 | 11 | 0.220 |
Why?
| | Female | 37 | 2025 | 75943 | 0.220 |
Why?
| | Rural Population | 3 | 2024 | 606 | 0.210 |
Why?
| | Obesity | 5 | 2023 | 3008 | 0.210 |
Why?
| | Neurofilament Proteins | 1 | 2024 | 62 | 0.210 |
Why?
| | Healthcare Disparities | 3 | 2024 | 673 | 0.210 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2024 | 112 | 0.210 |
Why?
| | Trisomy | 1 | 2025 | 79 | 0.210 |
Why?
| | Urban Population | 2 | 2024 | 485 | 0.200 |
Why?
| | Child | 17 | 2025 | 22414 | 0.200 |
Why?
| | Colorado | 9 | 2025 | 4629 | 0.200 |
Why?
| | Food Assistance | 1 | 2023 | 33 | 0.190 |
Why?
| | Postpartum Period | 2 | 2023 | 354 | 0.190 |
Why?
| | Genetic Linkage | 2 | 2022 | 288 | 0.180 |
Why?
| | Cardiovascular Diseases | 3 | 2025 | 2096 | 0.180 |
Why?
| | Dental Caries | 1 | 2023 | 173 | 0.180 |
Why?
| | Humans | 43 | 2025 | 141754 | 0.180 |
Why?
| | Physicians, Primary Care | 1 | 2024 | 226 | 0.180 |
Why?
| | Gender Dysphoria | 1 | 2021 | 20 | 0.180 |
Why?
| | Male | 28 | 2025 | 70179 | 0.180 |
Why?
| | Electronic Health Records | 3 | 2025 | 1132 | 0.170 |
Why?
| | Disorders of Sex Development | 1 | 2021 | 39 | 0.170 |
Why?
| | Mood Disorders | 1 | 2021 | 141 | 0.160 |
Why?
| | Dyslipidemias | 1 | 2022 | 175 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2024 | 1406 | 0.150 |
Why?
| | Practice Patterns, Physicians' | 2 | 2024 | 1344 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 301 | 0.150 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2019 | 36 | 0.150 |
Why?
| | Case-Control Studies | 5 | 2025 | 3597 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2023 | 1027 | 0.150 |
Why?
| | Logistic Models | 5 | 2021 | 2092 | 0.150 |
Why?
| | United States | 12 | 2025 | 15310 | 0.150 |
Why?
| | Communication | 1 | 2025 | 951 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 93 | 0.140 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 37 | 0.140 |
Why?
| | Osteoprotegerin | 1 | 2017 | 25 | 0.140 |
Why?
| | Genome-Wide Association Study | 2 | 2022 | 1406 | 0.140 |
Why?
| | Child, Preschool | 8 | 2025 | 11512 | 0.140 |
Why?
| | Precision Medicine | 1 | 2022 | 434 | 0.140 |
Why?
| | Cardiologists | 1 | 2017 | 45 | 0.140 |
Why?
| | Exome | 1 | 2019 | 238 | 0.130 |
Why?
| | Organizations, Nonprofit | 1 | 2017 | 18 | 0.130 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 18 | 0.130 |
Why?
| | Birth Order | 1 | 2017 | 13 | 0.130 |
Why?
| | Adult | 16 | 2025 | 39391 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 406 | 0.130 |
Why?
| | Population Density | 1 | 2017 | 97 | 0.130 |
Why?
| | Infant | 8 | 2025 | 9843 | 0.130 |
Why?
| | Qualitative Research | 1 | 2024 | 1547 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2018 | 223 | 0.130 |
Why?
| | Hearing Tests | 1 | 2017 | 47 | 0.130 |
Why?
| | Parenting | 1 | 2020 | 320 | 0.130 |
Why?
| | Health Promotion | 3 | 2023 | 759 | 0.120 |
Why?
| | Genome, Human | 1 | 2019 | 421 | 0.120 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1183 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 708 | 0.120 |
Why?
| | Blood Pressure | 2 | 2022 | 1748 | 0.120 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 5697 | 0.120 |
Why?
| | Young Adult | 9 | 2025 | 13749 | 0.120 |
Why?
| | Renal Dialysis | 3 | 2009 | 457 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2017 | 172 | 0.120 |
Why?
| | Aftercare | 1 | 2017 | 218 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 547 | 0.110 |
Why?
| | Depression | 1 | 2025 | 1508 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 626 | 0.110 |
Why?
| | Prevalence | 4 | 2025 | 2799 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 506 | 0.110 |
Why?
| | Adolescent Health Services | 1 | 2015 | 76 | 0.110 |
Why?
| | Odds Ratio | 3 | 2021 | 1057 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 624 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 339 | 0.110 |
Why?
| | Middle Aged | 14 | 2025 | 34647 | 0.110 |
Why?
| | Infant, Newborn | 6 | 2023 | 6289 | 0.100 |
Why?
| | Genetic Variation | 1 | 2019 | 1000 | 0.100 |
Why?
| | Hearing Loss | 1 | 2017 | 235 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 385 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4190 | 0.100 |
Why?
| | Age of Onset | 2 | 2025 | 534 | 0.100 |
Why?
| | Prediabetic State | 1 | 2016 | 251 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 928 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2193 | 0.090 |
Why?
| | Risk Assessment | 1 | 2021 | 3508 | 0.090 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2024 | 213 | 0.090 |
Why?
| | Kidney Failure, Chronic | 2 | 2009 | 599 | 0.090 |
Why?
| | Poverty | 3 | 2023 | 530 | 0.090 |
Why?
| | Patient Compliance | 1 | 2016 | 611 | 0.090 |
Why?
| | Urban Health Services | 2 | 2021 | 69 | 0.080 |
Why?
| | Aged | 9 | 2025 | 24746 | 0.080 |
Why?
| | Propensity Score | 2 | 2021 | 332 | 0.080 |
Why?
| | Estradiol | 2 | 2023 | 528 | 0.080 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 5974 | 0.070 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2009 | 19 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 90 | 0.070 |
Why?
| | Retrospective Studies | 7 | 2021 | 16374 | 0.060 |
Why?
| | Risk Factors | 5 | 2021 | 10482 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2257 | 0.060 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 103 | 0.060 |
Why?
| | Minority Groups | 2 | 2018 | 278 | 0.060 |
Why?
| | XYY Karyotype | 1 | 2025 | 23 | 0.060 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2025 | 17 | 0.060 |
Why?
| | Time Factors | 4 | 2018 | 6966 | 0.060 |
Why?
| | Washington | 1 | 2025 | 160 | 0.060 |
Why?
| | Guatemala | 2 | 2016 | 347 | 0.050 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 77 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 696 | 0.050 |
Why?
| | Heart Failure | 1 | 2017 | 2093 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 1 | 2025 | 68 | 0.050 |
Why?
| | Muscular Atrophy | 1 | 2005 | 87 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 75 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5212 | 0.050 |
Why?
| | Cohort Studies | 3 | 2022 | 5815 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2007 | 308 | 0.050 |
Why?
| | Smoking | 2 | 2024 | 1603 | 0.050 |
Why?
| | Dental Hygienists | 1 | 2023 | 14 | 0.050 |
Why?
| | Neuroglia | 1 | 2024 | 173 | 0.050 |
Why?
| | Motivational Interviewing | 1 | 2025 | 118 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 2 | 2022 | 881 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2005 | 184 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 9 | 0.050 |
Why?
| | Cigarette Smoking | 1 | 2024 | 103 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2024 | 98 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7923 | 0.050 |
Why?
| | Linear Models | 2 | 2017 | 858 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2022 | 169 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2024 | 854 | 0.040 |
Why?
| | Lower Extremity | 1 | 2005 | 439 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 720 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 143 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 282 | 0.040 |
Why?
| | Autism Spectrum Disorder | 1 | 2025 | 419 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1664 | 0.040 |
Why?
| | Influenza Vaccines | 1 | 2024 | 551 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 6 | 0.040 |
Why?
| | Mental Health | 1 | 2025 | 759 | 0.040 |
Why?
| | Testosterone | 1 | 2022 | 405 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 57 | 0.040 |
Why?
| | Suicidal Ideation | 1 | 2024 | 545 | 0.040 |
Why?
| | Attitude | 1 | 2020 | 261 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2021 | 284 | 0.040 |
Why?
| | Quality of Life | 2 | 2007 | 3014 | 0.040 |
Why?
| | Mentors | 1 | 2020 | 212 | 0.040 |
Why?
| | Mississippi | 1 | 2017 | 21 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 219 | 0.030 |
Why?
| | Nuclear Family | 1 | 2018 | 57 | 0.030 |
Why?
| | Hospitalization | 2 | 2024 | 2264 | 0.030 |
Why?
| | Health Personnel | 1 | 2024 | 738 | 0.030 |
Why?
| | Mastectomy | 1 | 2018 | 153 | 0.030 |
Why?
| | Patient Care Team | 1 | 2023 | 673 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 381 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1826 | 0.030 |
Why?
| | Alcoholism | 1 | 2024 | 823 | 0.030 |
Why?
| | Health Behavior | 1 | 2023 | 792 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2024 | 835 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 476 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2938 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2018 | 239 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 7092 | 0.030 |
Why?
| | Maternal Age | 1 | 2017 | 128 | 0.030 |
Why?
| | Pediatricians | 1 | 2018 | 131 | 0.030 |
Why?
| | Suicide | 1 | 2024 | 671 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2019 | 232 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 381 | 0.030 |
Why?
| | Emigration and Immigration | 1 | 2017 | 56 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2024 | 1027 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 177 | 0.030 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 27 | 0.030 |
Why?
| | Peru | 1 | 2016 | 61 | 0.030 |
Why?
| | Haemophilus Vaccines | 1 | 2016 | 30 | 0.030 |
Why?
| | Income | 1 | 2017 | 201 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 224 | 0.030 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2016 | 47 | 0.030 |
Why?
| | Rotavirus Vaccines | 1 | 2016 | 42 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1768 | 0.030 |
Why?
| | Hepatitis B Vaccines | 1 | 2016 | 43 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 76 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1448 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 406 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2016 | 97 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1621 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3177 | 0.030 |
Why?
| | Cell Phone | 1 | 2016 | 82 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1656 | 0.030 |
Why?
| | Educational Status | 1 | 2017 | 464 | 0.030 |
Why?
| | Prognosis | 3 | 2009 | 4080 | 0.030 |
Why?
| | Women's Health | 1 | 2017 | 311 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1757 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 590 | 0.030 |
Why?
| | Echocardiography | 1 | 2017 | 648 | 0.030 |
Why?
| | Insurance, Health | 1 | 2017 | 299 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1401 | 0.030 |
Why?
| | Immunization Schedule | 1 | 2016 | 203 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 516 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2022 | 2135 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1924 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1317 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1498 | 0.030 |
Why?
| | Immunization Programs | 1 | 2016 | 221 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2018 | 498 | 0.030 |
Why?
| | Primary Health Care | 1 | 2024 | 1809 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2375 | 0.020 |
Why?
| | Vascular Stiffness | 1 | 2017 | 449 | 0.020 |
Why?
| | Medicaid | 1 | 2017 | 451 | 0.020 |
Why?
| | Body Mass Index | 2 | 2016 | 2385 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 753 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2017 | 566 | 0.020 |
Why?
| | Ambulatory Care | 1 | 2017 | 587 | 0.020 |
Why?
| | Caregivers | 1 | 2020 | 943 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 2063 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 930 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2112 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1977 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 961 | 0.020 |
Why?
| | Cognition | 1 | 2018 | 1228 | 0.020 |
Why?
| | Mothers | 1 | 2016 | 785 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1570 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 329 | 0.020 |
Why?
| | Japan | 1 | 2007 | 133 | 0.020 |
Why?
| | Europe | 1 | 2007 | 411 | 0.020 |
Why?
| | Electric Impedance | 1 | 2005 | 112 | 0.010 |
Why?
| | Survival Rate | 1 | 2009 | 1972 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 409 | 0.010 |
Why?
| | Survival Analysis | 1 | 2006 | 1320 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2075 | 0.010 |
Why?
| | Gait | 1 | 2005 | 317 | 0.010 |
Why?
| | Body Composition | 1 | 2005 | 703 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11181 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2005 | 647 | 0.010 |
Why?
| | Walking | 1 | 2005 | 548 | 0.010 |
Why?
|
|
Furniss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|